Influenza Vaccine Uptake Among Healthcare Workers
NCT05521763 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3000
Last updated 2022-09-15
Summary
Background:
1. Burden: Health-care workers (HCWs), such as doctors, nurses, and support staff involved in direct or indirect patient care, are at increased risk of influenza virus infections. HCWs may also transmit and spread influenza among hospitalized patients and other caregivers. HCWs often (40-83%) work while experiencing influenza-like illness (ILI), increasing the likelihood of influenza transmission to colleagues and patients.
2. Knowledge gap: Despite the World Health Organization recommendation for seasonal influenza vaccination among priority target groups such as health care workers, the low-income country such as Bangladesh lacks a seasonal influenza vaccination policy among this high-risk group, and vaccine uptake remains low.
3. Relevance: This study aims to generate preliminary data on HCWs willingness to get seasonal influenza vaccines following vaccine availability and factors associated with vaccine uptakes. The data from the study will support policymakers to increase awareness and develop influenza vaccination policy among top priority groups such as health care workers.
Hypothesis: The investigators hypothesize that awareness and availability of influenza vaccine supply would increase influenza vaccine uptake among health care workers
Objectives:
1. To assess influenza vaccine uptake among healthcare workers (HCWs) following awareness and availability of influenza vaccine supply in study hospitals
2. To explore HCWs barriers and Motivators for influenza vaccine uptake
3. To understand policy makers' perspectives on the feasibility of influenza vaccination among HCWs and to share with the National Immunization Technical Advisory Group (NITAG) for a policy decision regarding influenza vaccination
Methods:
The study will be conducted at four tertiary-level public teaching hospitals in Bangladesh. The investigators will use a cluster randomized controlled trial design. The intervention will be randomly allocated at the facility level and will include four arms: i) availability of influenza vaccine supply; ii) influenza vaccine awareness; iii) both influenza vaccine supply and influenza vaccine awareness, and iv) control arm with no intervention. The investigators will assess influenza vaccine uptake before and after intervention and between different study arms. The investigators will also explore the barriers and motivators of vaccine uptake using a qualitative approach. To understand the policy makers' perspectives and opinions regarding influenza vaccination among health care workers, the investigators will conduct in-depth interviews.
Outcome measures/variables:
1. The proportion of influenza vaccine uptake among health care workers before and after intervention and between different study arms
2. Different motivators and barriers to influenza vaccine uptake
Conditions
- Influenza Vaccines
Interventions
- BEHAVIORAL
-
ensuring the availability of influenza vaccine supply & developing influenza vaccine awareness
The four interventions will be: i) ensuring the availability of influenza vaccine supply; ii) developing influenza vaccine awareness; iii) both ensuring influenza vaccine supply and developing influenza vaccine awareness and iv) control arm with no intervention.
Sponsors & Collaborators
-
Institute of Epidemiology, Disease Control and Research
collaborator OTHER -
Sylhet M.A.G.Osmani Medical College
collaborator OTHER -
Mymensingh Medical College Hospital
collaborator UNKNOWN -
Rajshahi Medical College
collaborator OTHER -
Khulna Medical College Hospital
collaborator UNKNOWN -
Centers for Disease Control and Prevention
collaborator FED -
International Centre for Diarrhoeal Disease Research, Bangladesh
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-12
- Primary Completion
- 2022-12-29
- Completion
- 2023-02-12
Countries
- Bangladesh
Study Locations
More Related Trials
-
Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw
NCT04569019 ·Status: UNKNOWN
-
Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays Units
NCT02198638 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.
NCT00265161 ·Status: COMPLETED
-
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households
NCT00981513 ·Status: COMPLETED ·Phase: PHASE4
-
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
NCT03278067 ·Status: COMPLETED
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Responses in Health Care Personnel
NCT03323112 ·Status: RECRUITING
-
Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
NCT07310472 ·Status: RECRUITING ·Phase: NA
-
An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh
NCT04998344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly
NCT02741843 ·Status: COMPLETED ·Phase: NA
-
Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit
NCT02758145 ·Status: COMPLETED ·Phase: NA
-
Improving Influenza Vaccination Rates Among Health Care Professionals
NCT00404664 ·Status: COMPLETED ·Phase: NA
-
The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
NCT02565277 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Surveillance for Adverse Events Following Influenza Immunization
NCT01318876 ·Status: COMPLETED
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
NCT05215327 ·Status: RECRUITING ·Phase: PHASE2
-
From Innovation to Solutions: Childhood Influenza Vaccination Planning
NCT01664793 ·Status: COMPLETED ·Phase: NA
-
Vaccine Chatbot for Improving Influenza Vaccination Uptake
NCT06657573 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Flu Shot Pre-visit Questionnaire
NCT05508698 ·Status: COMPLETED ·Phase: NA
-
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 ·Status: COMPLETED
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED
-
Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
NCT02623075 ·Status: COMPLETED